MYoroface – The company behind IQoro
Myoroface is the company behind IQoro. We are a research-based healthtech company based in Hudiksvall in northern Sweden.
An improved quality of life
IQoro contributes to an improved quality of life by treating the root cause behind some of the most common public diseases.
- 97% improve their symptoms, sleep better and get the opportunity to reduce their medication.
We are doing everything we can to ensure that our customers succeed with their treatment. That’s something we are very proud of.
Våra kärnvärden
Engagemang
Vi brinner för att hjälpa människor. Vi tror att vi gör det bäst genom att engagerat bidra med det vi är experter på.
Nyfikenhet
Som en startup inom medtech är vi nyfikna. Vi ställer frågor, funderar på nya lösningar och vill ta reda på mer.
Omtanke
Hjärtat i vårt företag är vår omtanke. Omtanken om våra kunder och deras hälsa, men också omtanken om varandra.
Lösningsfokus
Vi gör allt för att våra kunder ska lyckas med sin behandling. Vi ser möjligheter istället för problem.
The innovator behind IQoro
Mary Hägg is both the brain and the heart behind IQoro.
With great patience and impressive anatomical knowledge, she has spent the majority of her professional life creating and developing IQoro.
Team IQoro
Working with IQoro means doing good things! We are a healthtech company that really cares about our customers. If you ask any of our employees what they think is the best thing about working with us, you will almost always get the same answer: We love helping people to a better quality of life.
Work with us!
We are constantly growing, and are therefore always on the lookout for new talents. Maybe you will become our next colleague?
- Current vacancies (Jobylon)
Partnership with RefluxUK
We are partnering with RefluxUK – the largest reflux specialist clinic in the UK.
Milestones
MYoroface was founded in 2012 and completed its first investment round in 2014 for continued market expansion.
Among the investors are ALMI Invest, Karlsarvet Invest and the Swedish Dragons’ Den profile Shervin Razani.
The company’s growth took off when IQoro began to be sold directly to consumers in the Nordics and the UK. Today IQoro is used by more than 100,000 people, and since May 2022 the product can be prescribed throughout the UK.
Contact
Call us from the UK: 01229 444 823
Call us from other countries +46 10 551 67 22
Email: info@iqoro.com
Organization number: 556902-6791
Hudiksvall (HQ)
MYoroface AB
Sjötullsgatan 16
824 55 Hudiksvall
Sweden
Göteborg:
MYoroface AB
c/o Mindpark Göteborg Central
Lilla Bommen 3
411 04 Göteborg
Sweden